Recent findings from peer-reviewed publications and clinical registries, explained in plain language. Each finding includes its evidence stage and a link to the original source.
Understanding evidence levels▼
PreclínicoLab or cell studies — no human data yet.
Estudio en animalesResults in animals only — may not apply to humans.
Ensayo Fase 1First-in-human safety testing in small groups.
Ensayo Fase 2Early effectiveness testing in a larger group.
Ensayo Fase 3Large controlled trial — the strongest trial evidence.
Estudio observacionalPatterns observed in populations — not a controlled trial.
RevisiónSummary analysis of multiple existing studies.
MetaanálisisStatistical pooling of results from multiple studies.
Estudio de laboratorioExperimentos de laboratorio en células o tejidos. Sin datos humanos ni animales.Lung CancerPublished: May 23, 2026
FAM72A Gene Linked to Lung Cancer Progression
Researchers studied the role of the FAM72A gene in lung cancer and found that it may contribute to the growth and spread of lung cancer cells. They discovered this by looking at lung cancer cells in the lab and seeing how they behaved when the FAM72A gene was turned off. The study suggests that the FAM72A gene may be involved in a signaling pathway that helps lung cancer cells grow and move.
Why it matters: This finding could help scientists understand how lung cancer progresses and potentially identify new targets for treatment.
This study was conducted in lab experiments using lung cancer cell lines, and further research is needed to confirm these findings in humans.
Estudio de laboratorioExperimentos de laboratorio en células o tejidos. Sin datos humanos ni animales.Lung CancerPublished: May 23, 2026
MET Exon 14 Skipping MutationA change in DNA sequence that can drive cancer development.Click for full explanation → in Non-Small Cell Lung Cancer
Researchers studied 585 patients with a specific genetic mutationA change in DNA sequence that can drive cancer development.Click for full explanation → in their lung cancer. They found that this mutationA change in DNA sequence that can drive cancer development.Click for full explanation → was more common in patients with a certain type of lung cancer and was often associated with other genetic changes. The study also identified potential reasons why some patients' cancer may not respond to certain treatments.
Why it matters: This finding highlights the need for further research into targeted therapiesDrugs that block specific molecules that cancer cells need to grow.Click for full explanation → for patients with this genetic mutationA change in DNA sequence that can drive cancer development.Click for full explanation →.
Estudio observacionalPatrones observados en poblaciones a lo largo del tiempo, no es un experimento controlado.Lung CancerPublished: May 22, 2026
Rare Bone Condition Linked to Lung Tumour
Researchers described a rare condition called hypertrophic pulmonary osteoarthropathy, which causes bone growth and joint pain. A man in his 60s was diagnosed with this condition after visiting a foot clinic. Further investigation revealed a lung tumour.
Why it matters: This finding highlights the importance of considering systemic causes for bone and joint symptoms.
Estudio observacionalPatrones observados en poblaciones a lo largo del tiempo, no es un experimento controlado.Lung CancerPublished: May 22, 2026
New Imaging Tool Helps Diagnose Pleural Diseases
Researchers used a special microscope to examine patients with pleural effusion, a condition where fluid builds up in the space between the lungs and chest wall. They found that the microscope images could help distinguish between benign and malignant pleural diseases, but more study is needed. The study included 18 patients and found that certain characteristics of the images could be useful for diagnosis.
Why it matters: This finding could lead to more accurate diagnoses and better treatment options for patients with pleural diseases.
The study had a small sample size and included only patients with pleural effusion of unknown etiology.
Estudio de laboratorioExperimentos de laboratorio en células o tejidos. Sin datos humanos ni animales.Lung CancerPublished: May 22, 2026
Researchers Identify New BiomarkersA measurable biological signal used to detect disease or predict treatment response.Click for full explanation → for Lung Cancer
Scientists studied lung cancer cells to find new markers that could help diagnose and treat the disease. They identified four genes that play a key role in the immune system and are often downregulated in lung cancer. These genes may help doctors predict patient outcomes and develop new treatments.
Why it matters: This finding could lead to more accurate diagnoses and better treatment options for lung cancer patients.
The study was conducted in lab experiments using lung cancer cell lines.
Estudio en animalesResultados solo en animales. Puede o no aplicarse a humanos.Lung CancerPublished: May 22, 2026
Macrophages in Cancer Tumors May Weaken Immune Response
Researchers studied how macrophages in cancer tumors affect the immune response. They found that these cells produce a protein called fibronectin, which may make tumors stiffer and less responsive to the immune system. This could limit the effectiveness of immunotherapyTreatments that use the body's immune system to fight cancer.Click for full explanation →.
Why it matters: This finding could help scientists understand why some cancer treatments don't work as well as expected and identify new targets for improving immunotherapyTreatments that use the body's immune system to fight cancer.Click for full explanation →.
This study was conducted in mouse models and may not directly apply to humans.
Estudio en animalesResultados solo en animales. Puede o no aplicarse a humanos.Breast CancerPublished: May 22, 2026
New Biodegradable Implant Helps Doctors Locate Cancer Tumors
Researchers created a new implant made of a soft, biodegradable material that can be used to mark cancer tumors. This implant uses sound waves to create a unique signature that can be seen on ultrasound images. In lab experiments, the implant worked well and didn't cause any harm to the animals tested.
Why it matters: This finding could help doctors more accurately locate and treat breast cancer.
Early-stage research, conducted in live pig and rat experiments.
Estudio observacionalPatrones observados en poblaciones a lo largo del tiempo, no es un experimento controlado.Breast CancerPublished: May 22, 2026
Rare Breast Condition Recurs Despite Surgery
Researchers reported a case of a young woman with a rare condition causing her breasts to grow abnormally large. Despite multiple surgeries, the condition recurred, causing significant distress. The researchers found that the condition was caused by benign breast tumors and abnormal growth of breast tissue.
Why it matters: This finding highlights the need for early and definitive treatment in patients with this rare condition.
Estudio de laboratorioExperimentos de laboratorio en células o tejidos. Sin datos humanos ni animales.Breast CancerPublished: May 22, 2026
IGF2BP3 protein linked to breast cancer spread
Researchers studied how a protein called IGF2BP3 affects breast cancer. They found that IGF2BP3 may help breast cancer spread by changing the way certain genes are expressed. This is an early finding that needs more research.
Why it matters: This study provides new insights into the biology of breast cancer and may help scientists develop new treatments in the future.
This study was conducted in a lab and has not been tested in people yet.
Estudio observacionalPatrones observados en poblaciones a lo largo del tiempo, no es un experimento controlado.Lung CancerPublished: May 22, 2026
Lymph Node Involvement Affects Lung Cancer Prognosis
Researchers studied 66 patients with early-stage lung cancer who had cancer in nearby lymph nodes. They found that certain factors, such as the type of lung cancer and whether the cancer had spread to other lymph nodes, affected how long patients lived after surgery. However, more research is needed to confirm these findings.
Why it matters: This study helps us understand how lymph node involvement affects lung cancer prognosis, which could inform future research and treatment decisions.
Efficacy
The mean overall survival was 59.7 months, and the disease-free survival was 52.0 months.
Small sample size (n=66) and retrospective analysis.
Estudio de laboratorioExperimentos de laboratorio en células o tejidos. Sin datos humanos ni animales.Lung CancerPublished: May 22, 2026
GFI1 Protein Boosts Immune Response in Cancer Cells
Researchers studied how a protein called GFI1 affects cancer cells' ability to fight off the immune system. They found that GFI1 is linked to higher levels of a protein that helps the immune system recognize cancer cells. This could make cancer cells more responsive to certain treatments.
Why it matters: This finding could lead to new ways to improve the effectiveness of immunotherapyTreatments that use the body's immune system to fight cancer.Click for full explanation → treatments for cancer.
Efficacy
Tumors with higher GFI1 levels showed a significantly better response to immunotherapy.
Tumor samples were from non-small cell lung cancer patients undergoing immunochemotherapy.
Estudio observacionalPatrones observados en poblaciones a lo largo del tiempo, no es un experimento controlado.Lung CancerPublished: May 22, 2026
Patient with lung cancer dies from pneumonia due to unusual hormonal imbalance
Researchers reported a case of a patient with small cell lung cancer who developed a severe infection after chemotherapyDrugs that kill rapidly dividing cells, including cancer cells.Click for full explanation →. Despite treatment, the patient died from pneumonia. The researchers think that an unusual hormonal imbalance may have weakened the patient's immune system, making them more susceptible to infection.
Why it matters: This finding may help doctors understand how some patients with lung cancer are more vulnerable to infections and how to better manage their care.
A single case report, which may not be representative of all patients with small cell lung cancer.
